Refers to infectious microbes that have acquired the ability to survive exposures to clinically-relevant concentrations of antimicrobial drugs that would kill otherwise sensitive organisms of the same strain. The phrase is also used to describe any pathogen that is less susceptible than its counterparts to a specific antimicrobial compound (or combination of both).